StonvexLoading…
StonvexStonvexStonvexCore line items from DSGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $478.03M | $1.80B | $1.32B | $855.62M |
Operating Income | $20.10M | $55.95M | $35.89M | $16.94M |
Net Income | $3.26M | $-7.33M | $18.59M | $1.90M |
EPS (Diluted) | $0.07 | $-0.16 | $0.39 | $-0.07 |
Total Assets | $1.76B | $1.73B | $1.78B | $1.61B |
Total Liabilities | $1.13B | $1.09B | $1.10B | $954.25M |
Cash & Equivalents | $65.44M | $66.48M | $61.34M | $46.79M |
Free Cash Flow OCF − CapEx | $-10.41M | $42.77M | $1.65M | $22.18M |
Shares Outstanding | 46.57M | 46.86M | 46.84M | 46.79M |